Product NDC: | 66521-112 |
Proprietary Name: | Fluvirin |
Non Proprietary Name: | Influenza Virus Vaccine |
Active Ingredient(s): | 15; 15; 15 ug/.5mL; ug/.5mL; ug/.5mL & nbsp; Influenza Virus Vaccine |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66521-112 |
Labeler Name: | Novartis Vaccines and Diagnostics Ltd |
Product Type: | VACCINE |
FDA Application Number: | BLA103837 |
Marketing Category: | BLA |
Start Marketing Date: | 19980812 |
Package NDC: | 66521-112-02 |
Package Description: | 10 SYRINGE in 1 CARTON (66521-112-02) > .5 mL in 1 SYRINGE |
NDC Code | 66521-112-02 |
Proprietary Name | Fluvirin |
Package Description | 10 SYRINGE in 1 CARTON (66521-112-02) > .5 mL in 1 SYRINGE |
Product NDC | 66521-112 |
Product Type Name | VACCINE |
Non Proprietary Name | Influenza Virus Vaccine |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19980812 |
Marketing Category Name | BLA |
Labeler Name | Novartis Vaccines and Diagnostics Ltd |
Substance Name | INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/URUGUAY/716/2007(H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) |
Strength Number | 15; 15; 15 |
Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL |
Pharmaceutical Classes | Inactivated Influenza A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient],Inactivated Influenza B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient] |